Hologic's 3-D Mammogram Gets FDA Panel's Blessing

In a 12-0 vote, an FDA panel has found Hologic's 3-D mammmography device to be safe. The panel stated that the Selenia Dimensions 3-D improves the detection of breast cancer when used with conventional 2-D mammography systems. The combination of 2-D mammography with Hologic's digital mammography tomosynthesis system could reduce recall rates and improve cancer detection.

September 27, 2010

1 Min Read
Hologic's 3-D Mammogram Gets FDA Panel's Blessing

"The system is designed to increase accuracy when screening women for the presence of cancerous tissue, and to enable a more precise characterization of suspicious lesions," says Jay A. Stein, cofounder and chief technical officer of Hologic. "I speak for all of Hologic in voicing great satisfaction that the FDA panel has weighed in so positively in favor of this valuable new tool in the battle to limit breast cancer mortality."

Selenia Dimensions is currently approved in countries in Europe, Latin America, and Asia, and is used in Canada and Mexico. The device is available in the United States as a 2-D system but would be upgraded to 3-D imaging if or when FDA approved.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like